ReviewCancers2025
Narrative Review of Single-Port Surgery in Genitourinary Cancers.
Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Comparative short-term efficacy and safety analysis of a single-port robot in nephrectomy.Journal of robotic surgery · 2025Pooled it
- Da Vinci Single-Port Robotic Surgery in Europe: Where Do We Stand? A Systematic Review.Journal of clinical medicine · 2025Review
- Descriptive analysis of initial experience with partial nephrectomy and retroperitoneal organ surgery using supine anterior retroperitoneal approach with the da Vinci SP robotic system: Pilot cases.Investigative and clinical urology · 2025Article
- Comparative outcomes of multi-port versus single-port robotic-assisted partial nephrectomy with same-day discharge: impact of surgical approach.Journal of robotic surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe da Vinci single-port (SP) platform is emerging as the latest innovation in minimally invasive surgery and its utilization in treating urologic malignancies continues to expand.
methodsA search was conducted in PubMed, MEDLINE, and ScienceDirect. The final set includes 40 academic articles.
resultsResearch on single-port surgery for genitourinary cancer is still an emerging topic. We divided the topic into the following categories: radical prostatectomy, radical cystectomy, nephrectomy, and nephroureterectomy.
conclusionsThe single-port platform provides urologists with another tool to tackle more complex surgical cases and pathologies with the added improvements of decreased length of stay and increased pain tolerance for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.